ライフサイエンスコーパス: peripartum cardiomyopathy

1 erican women are at increased risk of having peripartum cardiomyopathy.

2 imilar to those of patients with traditional peripartum cardiomyopathy.

3 entricular function in women presenting with peripartum cardiomyopathy.

4 Although the frequency of peripartum cardiomyopathy (185 of 100,000 deliveries) at

5 ne hundred women met traditional criteria of peripartum cardiomyopathy; 23 were diagnosed with pregna

6 e: idiopathic cardiomyopathy (616 patients), peripartum cardiomyopathy (51); and cardiomyopathy due t

7 verexpression of Galpha(q) exhibit a lethal, peripartum cardiomyopathy accompanied by apoptosis.

8 A comparison between the peripartum cardiomyopathy and early pregnancy-associated

9 rdiology, we identified 44 women who had had peripartum cardiomyopathy and had a total of 60 subseque

10 She was diagnosed with peripartum cardiomyopathy and treatment with digoxin and

11 Patients with peripartum cardiomyopathy appear to have a better progno

12 gy, clinical presentation, and management of peripartum cardiomyopathy, as well as the current knowle

13 shed from 1966 to July 1999, using the terms peripartum cardiomyopathy, cardiomyopathy, and pregnancy

14 idiopathic cardiomyopathy, the patients with peripartum cardiomyopathy had better survival (adjusted

15 For decades, peripartum cardiomyopathy has remained an enigma.

16 Peripartum cardiomyopathy has variable disease progressi

17 Mortality rates in peripartum cardiomyopathy have decreased, and this is mo

18 mation has also indicated that many cases of peripartum cardiomyopathy have genetic underpinnings.

19 Conversely, sNix protected against apoptotic peripartum cardiomyopathy in G(alpha)q-overexpressors.

20 view are to describe the clinical profile of peripartum cardiomyopathy in the United States and to pr

21 Peripartum cardiomyopathy is a cardiomyopathy of unknown

22 Peripartum cardiomyopathy is a heart disease of unknown

23 Peripartum cardiomyopathy is a potentially life-threaten

24 Peripartum cardiomyopathy is a pregnancy-associated myoc

25 Peripartum cardiomyopathy is a rare and sometimes fatal

26 Peripartum cardiomyopathy is a rare complication of preg

27 Peripartum cardiomyopathy is a rare lethal disease about

28 sequent pregnancy in women with a history of peripartum cardiomyopathy is associated with a significa

29 search in the past decade has suggested that peripartum cardiomyopathy is caused by vascular dysfunct

30 Management of peripartum cardiomyopathy is largely limited to the same

31 hy and myocarditis, but its effectiveness in peripartum cardiomyopathy is unknown.

32 cular function and survival in the Galpha(q) peripartum cardiomyopathy model.

33 5), hypertrophic cardiomyopathy (n = 40) and peripartum cardiomyopathy (n = 69) for disease-causing P

34 Based on clinical observations of peripartum cardiomyopathy patients and the high rate of

35 Peripartum cardiomyopathy patients had a high incidence

36 Peripartum cardiomyopathy patients had a mean age of 31+

37 For >50% of peripartum cardiomyopathy patients, left ventricular fun

38 this small retrospective study of women with peripartum cardiomyopathy, patients treated with immune

39 Peripartum cardiomyopathy (PPCM) and dilated cardiomyopa

40 t ventricular (LV) recovery in patients with peripartum cardiomyopathy (PPCM) and to record rates of

41 The term peripartum cardiomyopathy (PPCM) describes dilated cardi

42 Peripartum cardiomyopathy (PPCM) disproportionately affe

43 Peripartum cardiomyopathy (PPCM) is a life-threatening p

44 Peripartum cardiomyopathy (PPCM) is a pregnancy-associat

45 Peripartum cardiomyopathy (PPCM) is a rare life-threaten

46 Peripartum cardiomyopathy (PPCM) is an often fatal disea

47 Peripartum cardiomyopathy (PPCM) is the unexplained loss

48 this study was to systematically review the peripartum cardiomyopathy (PPCM) literature and determin

49 Peripartum cardiomyopathy (PPCM) remains a major cause o

50 psia is a risk factor for the development of peripartum cardiomyopathy (PPCM), but it is unknown whet

51 Black women are at greater risk for peripartum cardiomyopathy (PPCM).

52 imbalance during pregnancy may lead to acute peripartum cardiomyopathy (PPCM).

53 describe the characteristics and outcomes of peripartum cardiomyopathy (PPCMP) patients who received

54 Peripartum cardiomyopathy seems to affect women in diffe

55 omen had a 15.7-fold higher relative risk of peripartum cardiomyopathy than non-African Americans (od

56 men have significantly higher odds of having peripartum cardiomyopathy that could not be explained by

57 tutes of Health (NIH) convened a Workshop on Peripartum Cardiomyopathy to foster a systematic review

58 ared the clinical outcomes of six women with peripartum cardiomyopathy treated with intravenous immun

59 The frequency of peripartum cardiomyopathy varies markedly between Africa

60 U.S. studies confirmed that the frequency of peripartum cardiomyopathy was significantly higher among

61 icity remained a significant risk factor for peripartum cardiomyopathy when other risk factors were c

62 Given the poor prognosis of women with peripartum cardiomyopathy who do not improve, this thera

63 thy was a prospective 30-center study of 100 peripartum cardiomyopathy women with LV ejection fractio